22 September - 23 September 2026

A Celebration of Organic Chemistry 2026

Organised by:

SCI’s Fine Chemicals group

Macclesfield, UK

Register your interest
Synopsis
On Tuesday 22 and Wednesday 23 September 2026, influential researchers from across Europe will gather at AstraZeneca’s facility in Macclesfield to present a series of lectures on the latest developments in the field of organic chemistry. This event, jointly organised by SCI's Fine Chemicals Group and AstraZeneca, will celebrate the best of modern organic chemistry and will provide an overview of new methodologies and exciting applications in synthesis and beyond. The meeting will also provide a platform for early career researchers to share their vision for the future of organic chemistry. 
Attendees
Bringing together leading scientists from the organic chemistry community, this meeting will be of interest to those in academia and industry who are interested in developing and applying modern organic chemistry techniques to their research.
Confirmed speakers
The speakers will be confirmed in due course.


Programme

The programme will be confirmed in due course.


Exhibition

Please see the sponsorship pack and email conferences@soci.org to let us know which package you are interested in.


Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.


Venue and Contact

AstraZeneca

Mill Court
Charter Way
Macclesfield
Cheshire
SK10 2NA
UK 

 

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Booking Process/Deadlines

Booking terms and conditions


CPD Info

All delegates attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com


Sponsors

Organising committee
Dr Silvia Diez-Gonzalez, Imperial College London
Dr Dan Hamza, Sygnature 
Dr Chris Jones, Queen Mary University of London
Dr Kenneth Ling, Syngenta
Dr Wei Sun, AstraZeneca